(R)-Monepantel
CAS No. 887148-70-1
(R)-Monepantel( —— )
Catalog No. M37532 CAS No. 887148-70-1
(R)-Monepantel ((R)-AAD1566) has potential anticancer activity but no nematicidal activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 276 | In Stock |
|
| 10MG | 394 | In Stock |
|
| 25MG | 616 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(R)-Monepantel
-
NoteResearch use only, not for human use.
-
Brief Description(R)-Monepantel ((R)-AAD1566) has potential anticancer activity but no nematicidal activity.
-
Description(R)-Monepantel ((R)-AAD1566) has potential anticancer activity but no nematicidal activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number887148-70-1
-
Formula Weight473.39
-
Molecular FormulaC20H13F6N3O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO(C[C@](NC(=O)C1=CC=C(SC(F)(F)F)C=C1)(C#N)C)C2=C(C(F)(F)F)C=CC(C#N)=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Foxy-5 TFA(881188-51...
Foxy-5 is a peptide that mimics the WNT5A protein and is expected to reduce the mobility of the cancer cells. Foxy-5 triggers cytosolic free calcium signaling without affecting β-catenin activation and it impairs the migration and invasion of epithelial cancer cells.
-
ND-646
ND-646 is an orally bioavailable and allosteric inhibitor of the ACC enzymes ACC1 and ACC2(IC50s of 3.5 nM and 4.1 nM for recombinant hACC1 and hACC2, respectively)ND-646-an allosteric inhibitor of the ACC enzymes. ACC1 and ACC2 that prevents ACC subunit dimerization-to suppress fatty acid synthesis in vitro and in vivo.?
-
ML355
ML355, a specific, effective 12-Lipoxygenase(12-LOX) inhibitors(IC50=0.34 μM), possess favorable ADME properties.
Cart
sales@molnova.com